Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Gilbert

Showing results (201-210 of 337) with videos related to

Pageof 34
Sort By:
Lancet (London, England)|November 18, 2008
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialSusan P Buchbinder, Devan V Mehrotra, Ann Duerr, et al.
Journal of Virology|June 26, 2009
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donorsElin S Gray, Natasha Taylor, Diane Wycuff, et al.
Journal of Virology|December 14, 2011
Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccineHuma Qureshi, Zhong-Min Ma, Ying Huang, et al.
The Journal of Infectious Diseases|November 25, 2025
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure Proximal Design but Requires Far Fewer Blood SamplesDean Follmann, Lauren Dang, Eric Chu, et al.
Nature Communications|October 14, 2025
A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19Rhiannon Edge, Sam Matthews, Bahar Ahani, et al.
Current Opinion in Virology|February 1, 2016
Selection of HIV vaccine candidates for concurrent testing in an efficacy trialYing Huang, Carlos DiazGranados, Holly Janes, et al.
Human Immunology|October 12, 2021
Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in ThailandRasmi Thomas, Danaya Chansinghakul, Kriengsak Limkittikul, et al.
The Journal of Clinical Investigation|September 24, 2020
CMV viral load kinetics as surrogate endpoints after allogeneic transplantationElizabeth R Duke, Brian D Williamson, Bhavesh Borate, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine EvaluationYunda Huang, Oleg Borisov, Jia Jin Kee, et al.
Research Square|September 8, 2021
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine EvaluationYunda Huang, Oleg Borisov, Jia Jin Kee, et al.
Pageof 34

Showing results (201-210 of 337) with videos related to

Sort By:
Pageof 34
Lancet (London, England)|November 18, 2008
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialSusan P Buchbinder, Devan V Mehrotra, Ann Duerr, et al.
Journal of Virology|June 26, 2009
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donorsElin S Gray, Natasha Taylor, Diane Wycuff, et al.
Journal of Virology|December 14, 2011
Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccineHuma Qureshi, Zhong-Min Ma, Ying Huang, et al.
The Journal of Infectious Diseases|November 25, 2025
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure Proximal Design but Requires Far Fewer Blood SamplesDean Follmann, Lauren Dang, Eric Chu, et al.
Nature Communications|October 14, 2025
A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19Rhiannon Edge, Sam Matthews, Bahar Ahani, et al.
Current Opinion in Virology|February 1, 2016
Selection of HIV vaccine candidates for concurrent testing in an efficacy trialYing Huang, Carlos DiazGranados, Holly Janes, et al.
Human Immunology|October 12, 2021
Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in ThailandRasmi Thomas, Danaya Chansinghakul, Kriengsak Limkittikul, et al.
The Journal of Clinical Investigation|September 24, 2020
CMV viral load kinetics as surrogate endpoints after allogeneic transplantationElizabeth R Duke, Brian D Williamson, Bhavesh Borate, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine EvaluationYunda Huang, Oleg Borisov, Jia Jin Kee, et al.
Research Square|September 8, 2021
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine EvaluationYunda Huang, Oleg Borisov, Jia Jin Kee, et al.
Pageof 34